A primal roar tore through Lucius’s private office, rattling the antique inkwell on his mahogany desk. His knuckles, white and strained, gripped the edge of a data tablet, the screen displaying the grim confirmation: Alaric’s people had indeed breached his internal network. He hadn't just been outmaneuvered; he’d been *insulted*.
Cold fury, sharp and precise, replaced his initial rage. He wasn't one to suffer such a slight. Alaric Thorne would pay, not just in reputation, but in something far more tangible. Something that would bleed slowly, agonizingly.
Minutes later, his executive team scrambled into the room, their faces etched with trepidation. Lucius didn't waste breath on pleasantries. "Thorne Industries," he snarled, his voice a low growl. "Target MedVantage."
MedVantage. A cutting-edge medical tech startup, a pet project of Alaric’s, focusing on rare disease diagnostics. It was a subsidiary still in its nascent stages, heavily reliant on a single, complex supply chain and substantial ongoing investment. It was vulnerable, and it was personal.
His instructions were merciless. "Short-sell their stock into oblivion. Buy out their key suppliers at any cost. Spread rumors of product contamination. Make an unsolicited, ridiculously lowball offer for acquisition. I want it crippled. I want Thorne to bleed money keeping it afloat."
Across the city, Alaric sat through a seemingly endless board meeting, the drone of financial reports a distant hum. His phone, set to silent, vibrated with an urgency that broke through his focus. A message from his head of security. "Lucius hit us. MedVantage. Full assault."
Alaric's jaw tightened. He excused himself, the sudden shift in his demeanor sending a ripple of unease through the room. Stepping into his private elevator, he called his security chief, then his CFO, Michael.
"What's the damage?" Alaric demanded, his voice devoid of emotion, a dangerous calm settling over him.
Michael's voice was strained. "It's bad, sir. They've cornered the market on our primary diagnostic component. Our stock is plummeting. The acquisition offer is a joke, but the media's eating up the 'crisis' narrative. They're moving fast."
Protecting MedVantage wasn't just about financial loss. It was about his word. About the patients, about the researchers who’d poured their lives into it. And, he realized with a pang, it was about Sera. He knew she’d been drawn to the project’s humanitarian aspect. Lucius knew this, too.
Losing MedVantage would be a public relations disaster, a stain on Thorne Industries’ reputation, and a direct assault on the values Alaric was trying to build, especially after the recent revelations about his father. It would also leave Sera exposed, a vulnerability he couldn't tolerate.
Alaric stared out at the cityscape, his mind racing through calculations. Every option was grim. Let it fall? Unacceptable. Fight back directly? Too slow. Lucius had planned this, anticipating a counter-attack.
"We need to stabilize MedVantage," Alaric stated, his decision firm. "Inject capital. Buy out their suppliers back, whatever the premium. Issue a public statement. Reassure the market. Then, prepare for a hostile takeover defense. Whatever it costs."
Michael hesitated. "Sir, that will be an astronomical figure. It means diverting funds from the orbital energy project, delaying the European expansion, and potentially liquidating significant assets. It will be a massive hit to our Q3. We’re talking hundreds of millions, possibly more."
Alaric didn't flinch. "Do it. Clean house at MedVantage, secure their supply chain, and double down on their PR. I don't care about the short-term loss. This isn't just about MedVantage anymore. This is a declaration of war."
The financial sacrifice was immediate and brutal. Funds were reallocated with surgical precision, assets sold off at a lower-than-ideal price to generate the necessary liquidity. Thorne Industries took on a significant, calculated debt, a move that would sting for months, if not years.
Sera watched the news ticker flash across her tablet screen, her breath catching in her throat. "Thorne Industries faces unprecedented market pressure," one headline screamed. "MedVantage subsidiary in crisis," another declared. The stock charts showed a steep, alarming decline.
Realizing the depth of Alaric’s commitment, her internal conflict intensified. He was making this devastating sacrifice to protect something vital, something good, something she cared about. And by extension, to protect *her* from Lucius's insidious reach. His actions were a stark contrast to the betrayal she’d just uncovered concerning the Serpent’s Eye brooch.
His ruthlessness, his protectiveness, his complicated past – it all swirled together. How could she reconcile the man willing to sacrifice so much with the man whose family held her legacy hostage? The dichotomy was agonizing.
News of Thorne Industries’ massive financial hit reverberated through the stock market within hours. Analysts scrambled, their voices filled with speculation. Investors pulled back, cautious of the sudden instability. Lucius, with a cruel, satisfied smile, watched his screens, knowing he had just bought himself significant leverage. Thorne Industries, once unshakeable, now teetered on the brink, and Alaric, for the first time in a long time, was on the defensive.